Catalys Pacific Fund LP 13D and 13G filings for Mineralys Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-11-13 4:09 pm Sale |
2024-09-30 | 13G | Mineralys Therapeutics, Inc. MLYS |
Catalys Pacific Fund LP | 8,681,245 17.400% |
-528,000![]() (-5.73%) |
Filing |
2024-02-13 4:12 pm Purchase |
2023-12-31 | 13G | Mineralys Therapeutics, Inc. MLYS |
Catalys Pacific Fund LP | 9,209,245 22.400% |
9,209,245![]() (New Position) |
Filing |